1. Home
  2. AKA vs STIM Comparison

AKA vs STIM Comparison

Compare AKA & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo a.k.a. Brands Holding Corp.

AKA

a.k.a. Brands Holding Corp.

HOLD

Current Price

$10.67

Market Cap

105.4M

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$3.06

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKA
STIM
Founded
2018
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.4M
120.4M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
AKA
STIM
Price
$10.67
$3.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$24.33
$3.00
AVG Volume (30 Days)
2.7K
3.5M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.25
EPS
N/A
N/A
Revenue
$600,208,000.00
$52,776,000.00
Revenue This Year
$6.14
$11.10
Revenue Next Year
$4.89
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
4.44
N/A
52 Week Low
$8.42
$0.80
52 Week High
$16.38
$3.80

Technical Indicators

Market Signals
Indicator
AKA
STIM
Relative Strength Index (RSI) 47.51 72.57
Support Level $10.38 $1.21
Resistance Level $11.70 N/A
Average True Range (ATR) 0.43 0.26
MACD -0.09 0.11
Stochastic Oscillator 28.55 78.57

Price Performance

Historical Comparison
AKA
STIM

About AKA a.k.a. Brands Holding Corp.

a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: